Lifetime sales:$104 billion Advair is used to treat asthma and breathing from other lung diseases.4Advair received its approval in 2001 and has been a big seller since the beginning. The drug's U.S. patent expired in 2010 and its inhaler pattern expired in 2016, but no successful generic...
Combination inhaler therapy is now available for the treatment of asthma. These medications include Advair (fluticasone and salmeterol), Symbicort (budesonide and formoterol), and Dulera (mometasone and formoterol). Symbicort and Dulera use the standard MDI inhaler device with a dose counter. Advair h...